跳至主要内容
临床试验/ISRCTN46109513
ISRCTN46109513已完成未知

Six-year effects of the time-extended stimulation program on everyday memory in healthy older persons: a randomized controlled trial

City of Ponferrada (Ayuntamiento de Ponferrada) (Spain)0 个研究点目标入组 1,756 人开始时间: 2014年11月6日最近更新:

试验速览

阶段
未知
状态
已完成
发起方
入组人数
1,756

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Aged 65 years or over
  • 2. Senior retired community-dwelling persons living independently

排除标准

  • 1. Self-reported diagnoses of Alzheimer?s disease
  • 2. Severe sensory impairment (sight and/or hearing)
  • 3. Moderate dependence (need help to perform daily life activities more than twice a day)
  • 4. Unavailability during the study period

研究者

发起方
City of Ponferrada (Ayuntamiento de Ponferrada) (Spain)

相似试验

进行中(未招募)
不适用
The effect of progressive resistance training on knee articular cartilage morphology in osteoarthritic patientsMusculoskeletal - OsteoarthritisOsteoarthritis
ACTRN12605000116628niversity of Sydney, Faculty of Health Sciences, School of Exercise and Sport Science60
进行中(未招募)
1 期
Extension to the MAGNIFY MS trial on Mavenclad®Highly-active relapsing multiple sclerosisMedDRA version: 20.0Level: SOCClassification code 10029205Term: Nervous system disordersSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 20.1Level: PTClassification code 10028245Term: Multiple sclerosisSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 21.0Level: PTClassification code 10080700Term: Relapsing multiple sclerosisSystem Organ Class: 10029205 - Nervous system disorders
EUCTR2020-003995-42-CZMerck Healthcare KGaA261
进行中(未招募)
1 期
Extension to the MAGNIFY MS trial on Mavenclad®Highly-active relapsing multiple sclerosisMedDRA version: 20.0Level: SOCClassification code 10029205Term: Nervous system disordersSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 20.1Level: PTClassification code 10028245Term: Multiple sclerosisSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 21.0Level: PTClassification code 10080700Term: Relapsing multiple sclerosisSystem Organ Class: 10029205 - Nervous system disorders
EUCTR2020-003995-42-ATMerck Healthcare KGaA256
进行中(未招募)
1 期
Extension to the MAGNIFY MS trial on Mavenclad®
EUCTR2020-003995-42-PLMerck Healthcare KGaA256
进行中(未招募)
1 期
Extension to the MAGNIFY MS trial on Mavenclad®Highly-active relapsing multiple sclerosisMedDRA version: 21.1Level: PTClassification code 10063399Term: Relapsing-remitting multiple sclerosisSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 20.0Level: SOCClassification code 10029205Term: Nervous system disordersSystem Organ Class: 10029205 - Nervous system disordersMedDRA version: 20.1Level: PTClassification code 10028245Term: Multiple sclerosisSystem Organ Class: 10029205 - Nervous system disorders
EUCTR2020-003995-42-ITMERCK KGAA261